series-c-plus
Stage
1
Investors
About
Brainsway Ltd develops non-invasive medical devices based on patented Deep Transcranial Magnetic Stimulation (Deep TMS) technology to treat brain disorders, including clinical depression and obsessive-compulsive disorder (OCD). Their technology is FDA and CE cleared and was developed in collaboration with the National Institutes of Health.
Explore Brainsway Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.